Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients. - Wikidata - awgldk - TriplyDB

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.

http://www.wikidata.org/entity/Q33979025

about

A review of anti-inflammatory agents for symptoms of schizophrenia Molecular substrates of schizophrenia: homeostatic signaling to connectivity Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex.Oxidative stress and schizophrenia: recent breakthroughs from an old story Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia.Meta-analysis of oxidative stress in schizophrenia.Erythrocyte glutathione levels as long-term predictor of transition to psychosis Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics.The promise of biological markers for treatment response in first-episode psychosis: a systematic review.Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects.Comparative Study on Serum Levels of 10 Trace Elements in Schizophrenia NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.Antioxidants as potential therapeutics for neuropsychiatric disorders.No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia.Decreased zinc availability affects glutathione metabolism in neuronal cells and in the developing brain.Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.Long-Term Effects of Maternal Deprivation on Redox Regulation in Rat Brain: Involvement of NADPH Oxidase.Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach.Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment.Supplemental lipoic acid relieves post-weaning diarrhoea by decreasing intestinal permeability in rats.A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia.Peripheral levels of superoxide dismutase and glutathione peroxidase in youths in ultra-high risk for psychosis: a pilot study.Effects of omega-3 supplementation on interleukin and neurotrophin levels in an animal model of schizophrenia.Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs.Day/Night and Summer/Winter Changes in Serum Total Antioxidant Capacity.Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy.GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.The complex association between the antioxidant defense system and clinical status in early psychosis.Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for Psychosis.Nicorandil reverses the behavioral changes and brain oxidative stress in a model of schizophrenia induced by ketamine in mice

P2860

Q22241827-63D0E68F-2F92-45C5-B814-F0072BE42DC4 Q30383611-DD96CD64-6943-4389-AEF5-24C5DC768A2F Q30440988-94AEAC48-E76B-44E6-B8F4-5EB7208A2FCB Q30774039-9F58E1BA-4005-4595-989C-FB0FA2C01863 Q33589462-AA04C042-1906-4059-A97B-912B42FC1DE6 Q33601360-337E1BC2-9C6D-4760-B210-0B2F847510BB Q33635566-EA867310-C499-4C10-904D-B9012D670DD9 Q33647885-4C386586-B889-473C-AD0F-6E65EE7B2897 Q33904833-66EA8428-76D5-4B8D-A247-65027915E318 Q34599738-83D92C93-FD93-4861-9665-001C8FD6C362 Q34786239-BC7F4126-354B-496F-9967-38CB891784BD Q35369988-08D559EF-4B87-4C88-BE40-766CE1367609 Q35591134-0E3E338E-09F9-409A-94D4-80B93B4BA0FF Q35694385-C71DF5BC-A87E-4B40-915C-0EE67C95BDA7 Q35985407-B8FB6F39-FB39-4ED2-941C-83E6A23A71FE Q36736055-D82DB3A0-43D9-4D0C-9D41-9B7DE6DB0364 Q36756178-DDC37C83-D41A-4DF2-AAB3-189076817F12 Q36769345-05C67B93-67E2-45BB-A8E0-9B9E11AFAD7D Q36998471-154CAED0-6F2C-4158-8B48-B1992039EF9C Q37530729-783F64D2-360B-4800-8127-0E9B4DF47898 Q37734352-116E4FDA-08A4-483A-A5DC-7D72F41B8DE4 Q38154625-86823BA2-B56A-469F-8D7D-5CB805293507 Q41197010-2057C85A-8041-42C8-84C5-7EE75B27D9B0 Q41687474-FE913A7D-0817-4AC3-AFD7-6C73F80CFB9B Q41703320-14DD1EB2-64C7-4A2C-907A-CAD9790E22E4 Q42479721-E84046A3-E3C3-4F20-9B5C-A81DFDF10F9A Q42486880-AEF8F16A-A045-4CBE-9FE4-EBEC21DD1DB6 Q47093804-FB840E99-718F-4A2A-88D2-0B8C8E70A191 Q47297974-317B3D6E-B08F-4A48-ACEB-D28D1544CA8B Q47649451-3FC361AD-92B9-4907-AB8E-636B15EE4D25 Q49348765-76AFD3E5-2446-45F1-8AAF-05155EE0B6E5 Q50263200-374CCD1F-CF0E-420E-B5A4-790B89464248 Q50552178-085A4166-029D-40F4-8F7A-5F4A2E3C51ED Q50635567-F14727FA-134F-4321-8BA9-E50C5102DCEC Q52308849-42226147-DA8B-462A-B419-D77FF79FB46C Q55262427-5AF06E8B-DC34-493E-A0A0-566648268BDA Q57729831-F6D86E06-E086-41E7-BEB7-76B4E7F62933

P2860

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.

http://www.wikidata.org/entity/Q33979025

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Decreased glutathione levels a ...... pisode schizophrenic patients.

@ast

Decreased glutathione levels a ...... pisode schizophrenic patients.

@en

type

label

Decreased glutathione levels a ...... pisode schizophrenic patients.

@ast

Decreased glutathione levels a ...... pisode schizophrenic patients.

@en

prefLabel

Decreased glutathione levels a ...... pisode schizophrenic patients.

@ast

Decreased glutathione levels a ...... pisode schizophrenic patients.

@en

P1433

Q33979025-2122A88D-024A-442F-B65E-9528289ACA7F

P1476

Q33979025-C4A4D8D0-EA61-42DF-B468-13648B1AB639

P2093

Q33979025-2EDD9329-2E94-4B77-A5A4-1E9405700389

Q33979025-3E5264E6-4946-4DF6-9FE1-B476F6373269

Q33979025-4DF7E931-A59B-4ED6-A370-E481C146CCA1

Q33979025-675EEB91-E1F2-4CD3-8F62-5643AF63987B

Q33979025-C076202C-846F-4B6D-82B3-FCD61E06661C

P2860

Q33979025-24D1A305-276E-44BC-A398-9818669629DF

Q33979025-2F2D98A7-EDC3-4A73-9A7D-96AFAE5B794D

Q33979025-325EE8CD-7B37-46A8-A230-D51DC200149B

Q33979025-3B8E3C19-E1A3-4A47-93FA-E0C1FD15D4EE

Q33979025-3ECF6335-1995-46B3-8499-22785700ABD1

Q33979025-3FA26F12-E7A3-4274-9294-545B4E445088

Q33979025-4132A9CA-8084-4ECB-8EB6-F27BD1247AC5

Q33979025-422E9E98-336D-44D5-8B9F-B45808779126

Q33979025-508D0642-E0D1-44DE-851D-1C5ACACEFF2E

Q33979025-5A331892-EB98-4FBF-9993-5AE09EEA2516

P2888

Q33979025-44CEC1C3-5DB9-4C9F-BB05-2C3BFC5323FA

P304

Q33979025-44654BDA-89E1-4A87-ADA9-66576464C5FF

P31

Q33979025-02DBE180-A580-4E63-8276-4A30BD986E75

P356

Q33979025-651675C7-90FA-422C-9D9D-F443AEAFAF91

P478

Q33979025-8599623A-9D83-4C80-8037-F552E201D045

P577

Q33979025-AE7351D6-442E-431F-B892-DF79DBE8F6FD

P6179

Q33979025-2B12DE68-3ABE-4E7B-A835-278EFBAF07EF

P698

Q33979025-F47523FF-D78C-459B-BEF0-C0DCA04DE9ED

P921

Q33979025-3D726CDF-0D69-43BF-945C-9EC9A14FCC62

P932

Q33979025-71404625-0426-40C0-9FF6-20A9D06D4EB6

P356

1471-244X-11-124

P1433

P1476

Decreased glutathione levels a ...... pisode schizophrenic patients.

@en

P2093

Abdelhamid Kerkeni

http://www.w3.org/2001/XMLSchema#string

Ahmed Mhalla

http://www.w3.org/2001/XMLSchema#string

Anwar Mechri

http://www.w3.org/2001/XMLSchema#string

Fatma Atig

http://www.w3.org/2001/XMLSchema#string

Monia Raffa

http://www.w3.org/2001/XMLSchema#string

P2860

Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study

Cytotoxic and genotoxic potential of dopamine.

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment.

The antioxidant glutathione peroxidase family and spermatozoa: a complex story.

Oxidative stress in schizophrenia: an integrated approach.

Dopamine in schizophrenia: a review and reconceptualization.

P2888

1471-244x-11-124

P304

124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-244X-11-124

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037723913

http://www.w3.org/2001/XMLSchema#string

P698

21810251

http://www.w3.org/2001/XMLSchema#string

P921

P932

3161936

http://www.w3.org/2001/XMLSchema#string